Injective INJ
Current Price
$3.20 -0.91%
$0.1200 Daily Range (3.75%)
$3.15$3.27
$40.31M Daily Volume
573 BTC
Vol/MktCap: 12.60%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $40.31M over the past 24 hours, compared to $46.09B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.20 -0.03%
13 SMA $3.20 +0.13%
21 SMA $3.21 -0.41%
55 SMA $3.24 -1.14%
144 SMA $3.34 -4.32%
Price Performance
-0.58% 1 Hour Change
$3.20 from $3.22
-8.58% 7 Day Change
-$0.2745 from $3.47
-26.94% 14 Day Change
-$0.8619 from $4.06
-37.45% 30 Day Change
-$1.20 from $4.40
All Time High
March 14, 2024
$52.62 -93.90%
-$49.41 vs. now
24H Change
-2.95M USD -0.92%
-42 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
12.56M INJ
traded over past 24 hours
12.56% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.20, reflecting a 24-hour change of -2.39%. The price has fluctuated between a high of $3.28 and a low of $3.15 in the last day, indicating low volatility with a daily range of only 0.13%.
The trading volume over the last 24 hours is approximately 39.36 million, giving a volume-to-market cap ratio of 12.31%, suggesting moderate trading activity relative to market capitalization. The short-term hourly moving averages show mixed signals, with the 8 SMA at $3.19 indicating slight bullish momentum, while longer-term SMAs, particularly the 144 SMA at $3.36, reflect a bearish trend over the past few weeks.
Technical indicators such as the 1-hour and 7-day RSI are both at 45, suggesting that the asset is currently in neutral territory but leaning towards oversold conditions. Over the past week, INJ has seen a price drop of approximately 10.77%, and the 14-day change shows a more substantial decline of 25.76%, indicating sustained bearish sentiment in the market.
Injective’s all-time high of $52.62 reached in March 2024 highlights significant potential upside, but current price action suggests a considerable distance from that peak. The cumulative 30-day price change of -38.12% indicates a strong downtrend, which is a cause for caution among investors.
Given the current price action, negative momentum, and lack of bullish signals in the moving averages and RSI, a cautious stance is warranted. Based on this analysis, the recommendation for Injective (INJ) is a Sell rating, as the prevailing market conditions suggest further downside risk in the near term.
The trading volume over the last 24 hours is approximately 39.36 million, giving a volume-to-market cap ratio of 12.31%, suggesting moderate trading activity relative to market capitalization. The short-term hourly moving averages show mixed signals, with the 8 SMA at $3.19 indicating slight bullish momentum, while longer-term SMAs, particularly the 144 SMA at $3.36, reflect a bearish trend over the past few weeks.
Technical indicators such as the 1-hour and 7-day RSI are both at 45, suggesting that the asset is currently in neutral territory but leaning towards oversold conditions. Over the past week, INJ has seen a price drop of approximately 10.77%, and the 14-day change shows a more substantial decline of 25.76%, indicating sustained bearish sentiment in the market.
Injective’s all-time high of $52.62 reached in March 2024 highlights significant potential upside, but current price action suggests a considerable distance from that peak. The cumulative 30-day price change of -38.12% indicates a strong downtrend, which is a cause for caution among investors.
Given the current price action, negative momentum, and lack of bullish signals in the moving averages and RSI, a cautious stance is warranted. Based on this analysis, the recommendation for Injective (INJ) is a Sell rating, as the prevailing market conditions suggest further downside risk in the near term.
Updated 287 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Jack Dorsey’s Block Eyes 10% Workforce Reduction Amid Business Overhaul: Report
Payments firm Block Inc., led by Jack Dorsey, is preparing to cut as much as 10% of its workforce as it pushes deeper into an efficiency drive, according to a report from…

XRPL Powers $280M Diamond Tokenization as Ripple Expands Gulf Infrastructure
Ripple-backed blockchain infrastructure is pushing commodities onchain in the Gulf, with over $280 million in certified diamonds tokenized in the UAE, highlighting how…

Global crypto searches near 1‑year low at 30 as market cap slumps 43%
Global interest in crypto is at a year-long low, with Google searches dropping as the market cap falls 43%.

Bitcoin Price Cools Above $70K, Breakout Battle Near $72K Looms
Bitcoin price started a recovery wave from $60,000. BTC is now consolidating gains above $70,000 and faces hurdles near the $72,000 zone.